Cushing’s Disease is one of the most common endocrine disorders in dogs and within that group, 80-85% of the dogs have PDH, while the remaining 15% have a functional adrenal tumor. Mitotane is a commonly used treatment for PDH in dogs and approximately 80% of dogs with PDH will respond favorably to treatment. There are two different basic protocols for using mitotane in dogs with PDH.